December 4-6, 2017 |
Philadelphia, PA

Media Center

Laboratory Informatics Agenda 2017

Enter your details below to receive your event agenda.

Top Featured

Creating Private Data that is HIPAA Compliant

We sat down with Bruce Kozuma, the Senior Systems Analyst and Project Manager at The Broad Institute. He is working on a project concerning the quantification of laboratory resources to measure innovation, and discusses what he considers to be groundbreaking about this study. Furthermore he outlines steps to assure a biomedical research organization can build a sustainable system of creating private data so that the operations are compliant with HIPAA, and what the major benefits of ensuring HIPAA compliance in the early phases of research have been.

Value & Considerations When Upgrading Lab Informatics Systems

To upgrade or not to upgrade. That is the question. Below are some of the motivators and demotivators laid out by Ricardo Schiavo, LIMS Manager at Regeneron Pharmaceuticals, a previous speaker at the last Laboratory Informatics Summit. They provide information on what comes into play from a business and IT perspective when considering an upgrade of your lab informatics systems. They also supply brief considerations to take into account before getting started.


Lab informatics 2017 market research

Pharma IQ asked a set ofexperts to provide their insight into trends within the use of structured and unstructured data in the lab informatics world. Commentary is provided by Darryl Davies, Associate Director, Janssen.

Areas examined: 

  • Challenges of managing structured and unstructured data in software
  • Strengths of managing structured and unstructured data with software
  • Vendor selection
  • International data exchange
  • Investment trends
  • SmartLabs software

Laboratory Data Knowledge Management Report: What You Need to Know

This report examines the key trends in laboratory data knowledge management to find out more about the challenges and solutions shaping the future of the laboratory informatics landscape such as Big Data analytics in the laboratory, the evolution of laboratory informatics and achieving excellence in laboratory informatics.

Sponsorship Information


Please complete the fields below to receive your copy of the 13th Laboratory Informatics Summit Prospectus which includes:
        Sponsorship Opportunities
        Attendee Profile
        Sponsorship Packages


Digital security and data integrity in the lab

Pharma and biotech laboratories need to verify the integrity and security of their data to avoid regulatory action. Data hosted in digital systems is more vulnerable to corruption and unauthorised amends if not safeguarded by relevant procedures, password access and audit trails. Therefore, the computerised systems selected by labs need to be qualified to ensure that data integrity and security is preserved.

Exclusive Content

3 Strategies For Implementing an End-to-End Evaluation of Your Lab Informatics Database

Elizabeth Admirand, Principal Research Associate in Lead Discovery at Epizyme, outlines strategies in how they’ve been implementing an end-to-end evaluation of their lab informatics database, and what the major benefits of completing an end-to-end evaluation of their lab info systems have been. And discusses much more!

A “Cloud First” Mentality For The Life Sciences Industry

Christopher Waller Ph.D. is the Executive Director- MRLIT Modeling Platforms at Merck. He speaks to us about some key pre-competitive technology offerings such as cloud solutions, challenges being faced at Merck, and what has helped in addressing these. Chris also touches on what the Merck Research Laboratories team is currently working on, and how “cloud first” is there mantra. Also included are 5 steps for life sciences companies to consider before moving into cloud computing.

To receive a copy via email, contact

Making the Case for Cloud Adoption

We sat down with him ahead of the summit this June 26th - 28th in Philadelphia, PA. The below outlines how McBride was able to onboard cloud technology swiftly and effectively, which promoted optimized workflows for the present and future!

Expert Viewpoints from Pistoia Alliance & Shire

Carmen Nitsche, Executive Director of Business Development North America at Pistoia Alliance gives us her perspectives on "Pre-Competitive Activities & Initiating Cultural Change." Also Cindy Novak, Manager I, IT at Shire discusses "Perfecting Merger Management in IT."

Fast Track Your Attendance

Registration Form

Speed up your attendance by filling out the registration form and email back


Preparing Laboratory Data at the Broad Institute for HIPAA Compliance

Learn how preparation for HIPAA compliance has propelled the Broad’s aim of increasing the velocity of translation from discovery to therapy, understand the applicable HIPAA regulations and risks and how they differ from GxP regulations, and build a sustainable quality management framework for managing laboratory data compliant with HIPAA. Presentation by Bruce Kozuma, Senior Systems Analyst / Project Manager at the Broad Institute.

Refining Your Comprehensive IT Strategy to Support R&D Functions

Scott Arne Johnson, Associate Principal Scientist, Computational Chemistry and Cheminformatics at Merck, discusses implementing support solutions using internal services and external service providers for applications within R&D, working closely alongside project teams in order to implement informatics solutions and provide strategic device for buying decisions, evaluating and implementing tools for Big Data analytics for data integration and querying disparate data, and more.

Centralized Management of Laboratory Computers in R&D— Decrease Downtime and Lower TCO

Daniel Butcher, Senior Scientific Business Analyst at Regeneron Pharmaceuticals, speaks about how to determine the benefits of applying ITSM principles to laboratory computers and equipment, implementing an asset management system, consolidating hardware and software maintenance contracts, and more!


Bioinformatics: Data Knowledge Management With Complex Datasets

With the growth of biologics showing no signs of stopping, bioinformatics continues to be a key driver when it comes to R&D development. Ahead of this year's Lab Informatics Summit, Pharma IQ speaks to an array of experts on the subject of data knowledge management with complex datasets.

Fast Track Your Attendance

Justify Your Trip

Present your approving manager with this customizable letter detailing the reasons why you should attend the 14th Laboratory Informatics Summit, and you'll be sure to receive permission to join us.

Lab Informatics Toolkit

Thinking about attending the 14th Laboratory Informatics Summit? We are here to help you convince your colleague or manager to attend. Take a look at the top reason why you should attend. This toolkit includes:

  • Convince your boss letter
  • Top reasons to attend
  • Estimated Budget Expense Sheet
  • and more!

If you prefer to receive a copy please email 

Past Attendee Snapshot

Take a look at the executives - broken down by job title and company - who attended the last iteration of the Laboratory Informatics Summit. Will you be there this year?


Laboratory Informatics Market - Forecasts to 2021

This is a sample report courtesy of ASD Reports, The global laboratory informatics market is projected to grow during the forecast period of 2016 to 2021. The market for laboratory informatics solutions is expanding with the increasing need for laboratory automation, technological advancements, increasing availability of cost-effective informatics solutions, rising pressure to comply with regulatory requirements, and increasing adoption of laboratory informatics in biobanks/biorepositories, academic research institutes, and contract service organizations.

Exclusive Content

The Top 5 Principles of Analytics Proficiency

Here to help assess your organizations analytics capabilities, and move you into a direction of mature analytics proficiency is the “5 key principles of analytics proficiency.” Take a look at what improvements can be made to get you closer to your data-driven destination.


LIMS: Four Reasons Why Buying Is Better Than Building

The complexity of data in research and clinical genomics labs means a lab information management system (LIMS) is a necessity. A LIMS provides greater reproducibility of sample results, minimizes error introduced into the workflow, and enables greater user productivity. The question is no longer whether or not a LIMS is needed, but whether to build one or buy one. Courtesy of Genologics. 

The Smart Lab

Lab managers have “always-on” roles, serving as both strategic managers and the tactical

glue that holds operations together. With the movement to Smart Labs and Internet of

Things (IoT) technologies, a variety of new tools have emerged to support their increasingly

complex mission. In this paper, we will explore the opportunities for lab managers to take

full advantage of these technologies to meet their continuous improvement goals while

expanding their strategic impact on the organization as a whole.

If you would prefer to receive a copy, please email 

Five Ways a LIMS Accelerates Next-Generation Sequencing Research

An essential business tool for genomics labs courtesy of GenoLogics. This whitepaper goes into detail describing the five ways a LIMS accelerates next-generation sequencing research such as how a LIMS provides scale to keep cutting-edge labs on pace in a rapidly evolving discipline, can get labs up and running faster, and how it improves the integrity of results with unmatched sample traceability to name a few. Download for more!


Bioinformatics Expert Speaker Interview

Check out this brand new infographic interview to find out more about the unique metadata systems he’s implemented to:
Increase the “discoverability” of information
Allow scientists to know what to look for, and where to look for it, to simplify data retrieval
Save money and time in reducing data loss
Ken describes this project as “one of the most critical things we’re trying to do here at Proteostasis.” 

Vendor Partnerships and Leveraging the Cloud in Labs

There is an explosion of knowledge happening in pharma, but even with a slew of technological and scientific advances, how are we not witnessing a more productive R&D landscape? In the face of enormous R&D costs, it’s more important than ever to leverage every advantage the smart use of data has to offer.  The 14th Laboratory Informatics team reached out to Bob Coner, Associate Director, Research and Development Informatics at Peloton Therapeutics to give us insight on vendor partnerships and Chris Dwan, Former Director, Research Computing at the Broad Institute to fill us in on leveraging the cloud to streamline and cut costs. 

Expert Speaker Interviews Continued!

Following our exclusive speaker feature with Ken Longo, we sat down with 5 more of our past expert speakers.

8 Best Practices for Data Management

In this exclusive interview with Brian Wells, Associate Vice president for Health Technology and Academic Computing at the University of Pennsylvania Health System, he discusses with us some of the best practices within data management used at Penn Medicine, what is needed to be successful in this space, and why there seems to be such a lack of talent coming into it. Also what the main benefits to data aggregation and using data outside its original domain are, and where the future of lab informatics is headed.

IQ Content

Talking Heads: 9 Key Trends in Laboratory Informatics

Pharma IQ asked 9 international experts in the field of laboratory informatics to share their perspectives on key trends in the ever growing landscape of informatics in the laboratory.  
In this Pharma IQ Talking Heads, we discover the trends impacting this field and the barriers to achieving excellence in laboratory informatics. Plus, our 9 experts reveal  their top tips for creating an effective laboratory informatics strategy.


Trends in Usage of Lab Automation Software

Over the last few years, we’ve seen an explosion of adopting new scientific processes with new emerging technologies. Manufacturers are investing in agile research and manufacturing processes, to increase their ability to release products more rapidly, decrease engineering change cycle times, and increase asset and resource utilization.

Global Trends in Laboratory Data Knowledge Management Investment Till 2018

Pharma IQ surveyed lab informatics from key pharma and biotech companies to understand their key investment areas and plans in the next 12–18 months. This new infographic provides a first look of the survey results and highlights some of the key technologies and strategies they are looking to employ.

Pharma Quantified Facts and Figures Infographic

Pharma IQ presents a few statistics gathered from the medical press on today's drug discovery industry.

If you prefer to receive a copy, please email 

Standardization and Integration Tool Box

80% of lab informatics professionals highlighting laboratory integration as a long-term strategic goal within their organization. This infographic will provide you with top tips and insights on product development cycles and the implications for a fully integrated data management strategy; benefits of data standardization and the solutions available; how the Chief Data Officer at Covance improved R&D efficiency, how the Director of Information Protection at Sanofi prevents data loss and ensures the security of sensitive information against cyber threats and much more!


Data Sharing: How Pharma Can Benefit

As big data continues to transform healthcare, we need to overcome the ongoing reluctance to share data in order to unlock the benefits it can deliver. Katharine Briggs, Research Leader at Lhasa Limited, discusses some of the challenges surrounding the sharing of proprietary data and looks at how an honest broker can help.

Precision Medicine Research in the Million-Genome Era

 It’s an exciting time for genomics research, but the scale and complexity of these large population samples introduces new data challenges that require innovative and efficient approaches to analysis. By 2025, the annual acquisition of genomic data is anticipated to exceed 2 exabytes (2 million terabytes), and storing, accessing, and analyzing these data will be nontrivial.

If you would prefer to receive a copy, please feel free to email 

Visualization for Advanced Big Data Analysis

 A common challenge affecting many scientists, especially those working in the area of molecular biology, is the vast amount of data that is created by their experiments. With such a large volume of data to consider, advanced software tools are required to interpret their data effectively. We recommend a five-step method to ensure repeatable and significant results when using visualization to identify new subgroups and patterns in data.

If you would like to receive a copy instead please email 

The Cloud in China

Cloud systems have emerged in recent years as a strong trend in pharma informatics. Externalization has driven global integration applications that bring together multiple CRO and academic partners. Traditional technologies often fail in the complex security and high-latency networks required by these applications. The cloud would seem to be an ideal solution, but will it work in China? Read more at Pistoia Alliance.

What does AI really mean for big pharma?

Artificial intelligence could herald a new era for drug development but caution remains about how revolutionary its impact will actually be. AI is poised to become “the primary drug discovery tool by 2027,” according to AstraZeneca’s Global Head of Enterprise Architecture. But new artificial intelligence technologies remain ostensibly unproven in the field of pharma research and despite the hype and excitement it could yet take many years before patients reap the benefits.

If you would like to receive a copy via email instead, please email

Is Innovation without Transformation Insanity?

Does transforming ideas and discoveries into innovative products that improve patient outcomes or delight customers and consumers while reducing cost and improving ROI excite your shareholders? The ansiwer is obvious; the solution may not. For science-based companies, accelerating innovation cycles would result in shaving years and millions of dollars in expense from product R&D delivery.

If you prefer to receive a copy of this artilce, please email 


Pre-competitive Collaborations

Chris L. Waller, Ph.D. of Pistoia Alliance, discusses the rapidly evolving R&D ecosystem, research IT organizations facing the same challenges, applying a platform strategy to research, and how value driven from “horizontal” capabilities is a core differentiator of the MRL IT strategy.

Increasing Scalability and Laboratory Throughput by Consolidating Information Systems and Integrating Data Processes

Francesco DePierro, Director of Research Informatics, Vaccine R&D at Pfizer, Inc.discusses driving innovation thru technology and informatics, a typical clinical workflow, example study distribution, what the goal of change is. Also consolidating systems into a robust LIMS platform, replacing manual robotic fluid verification process, and developing a streamlined approach to software validation.

Optimizing Clinical Next-Generation Sequencing Efforts Through Cloud Computing

R. Mark Adams, Ph.D., Visiting Faculty from Bentley University, presents on the main challenges around cloud computing in order to support NGS advancement, solutions for mitigating potential security risks and privacy implications for using various vendors’ cloud platforms, utilizing cloud computing to handle the increased volume and complexity of data generated by NGS, and preparing a cost analysis of using cloud-based resources compared to similar on premise technologies.

How To Allocate Your Resources To Deal With The High Volume And Velocity Of Big Data

Daniel Butcher PhD from Lundbeck, discusses a case study of ELN Regulatory Compliance and Big Data, Using BioRails Functionality, Using Large File Storage, NetApp SnapLock, HCS Archive, how best to go about allocating resources, and more!

Building a Process Intelligence System for Drug Product Development

DadongLi, R&D Information Technology at Bristol-Myers Squibb, presents on the process intelligence system, and why you need it, the benefits of a process intelligence system, how it was designed and built as well as examples of how it performs.

Data-Driven Management of Laboratory Equipment - A Case for IT-Enabling Your Asset and Service Management Processes

Andrew Sargent, Director of Research IT Services at Bristol-Myers Squibb, presented at the 2016 Lab Informatics event this past January. Andrew discussed what BMS Research IT Services does, having access to all your information in one single place without manual manipulation. How they can help and what level of investment is right for there system, the holistic view and high level approach, working across multiple groups and breaking down silos, and much more!

Research Life Sciences Cloud (RLSC): A Platform Strategy for Research

This presentation by Brad Michel, Managing Director at Accenture and Farida Kopti PhD, Director of Chemistry/Pharmacology/HTS Informatics IT at Merck, discusses research informatics challenges, the RLSC feasibility study, the life sciences cloud and coalition as well as how it is governed. Also applying a platform strategy to research, how RLSC is focused on the early stages of the R&D value chain, phased releases, and a business case for RLSC.